Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access: APRN
      • NetCE All Access: MD
      • NetCE All Access: PA
      • NetCE All Access: RN
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights: APRN
      • Prescriber Insights: MD
      • Prescriber Insights: PA
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Gliptins

Gliptins

  • Diabetes (717)
    • Blood Glucose Meters (12)
    • Complications (121)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (104)
    • Monitoring (100)
    • Natural Medicines/Supplements (13)
    • Prevention (32)
    • Treatment (283)
      • Alpha-Glucosidase Inhibitors (20)
      • Amylin Agonist (16)
      • Bromocriptine (5)
      • Combination Products (20)
      • Gliptins (67)
      • Glitazones (96)
      • GLP-1 (29)
      • Incretin Enhancers/Mimetics (59)
      • Insulin (166)
      • Meglitinides (38)
      • Metformin (103)
      • SGLT2 Inhibitors (53)
      • Sulfonylureas (99)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (7)
  • Hyperglycemia (34)
  • Hypoglycemia (16)
  • Other (20)
  • Prediabetes (2)
  • Resources (166)
  • Thyroid Disorders (60)
46 - 60 of 67 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013) June 2013
Article: a new diabetes drug, Invokana (in-vo-KAHN-uh, canagliflozin) hit your pharmacy shelves May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis April 2013
Chart: Drug-Induced Pancreatitis April 2013
Article: how to manage diabetes during an acute illness March 2013
Commentary: Sick Day Management of Diabetes March 2013
Patient Education: How to Manage Sick Days with Diabetes March 2013
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
Commentary: Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes August 2012
Article: patients getting combinations of certain diabetes meds...Byetta with Januvia, Victoza with Onglyza, etc August 2012
Article: more emphasis on the prevention and treatment of type 2 diabetes in CHILDREN July 2012
Guideline: Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada July 2012
Article: new combo drug, Juvisync (JU-vih-sink), for treating diabetes November 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved